CTOs on the Move

Cure Alzheimer's Fund

www.curealz.org

 
Cure Alzheimers Fund is a non-profit organization that funds targeted research with the highest probability of preventing, slowing, or reversing Alzheimers disease.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.curealz.org
  • 34, Washington Street
    Wellesley, MA USA 02481
  • Phone: 781.237.3800

Executives

Name Title Contact Details

Similar Companies

Allure Healthcare Services

Allure Healthcare Services is a healthcare company that provides skilled nursing, assisted living, and independent senior living communities with quality care and operations management.

InAssist

InAssist is a El Segundo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sagamore Health Network

Sagamore Health Network, Inc. is a Carmel, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Carenet Health

Carenet Health is a leading provider of healthcare consumer engagement solutions, clinical support, health advocacy and navigation solutions, and 24/7 access to medical care. Our engagement specialists, care coordinators and registered nurses support 1 in 4 Americans (more than 86 million healthcare consumers) on behalf of 250+ of the nation`s premier health plans, providers, health systems and Fortune 500 organizations. Our mission is to drive market-leading consumer engagement outcomes through our proprietary Intelligent Engagement model. Our best-practice solutions are delivered by outstanding teams and backed by clinical capital, data and technology, operational excellence and expertise from outside of healthcare. Every day, our team members guide people to high-quality and cost-effective care, and coach them to close gaps in care and improve their health. For eight consecutive years, Inc. Magazine named Carenet as one of America`s fastest-growing private companies.

PharmaBlock Sciences

PharmaBlock Sciences (Nanjing), Inc. is a leading innovative chemistry products and services provider throughout the pharmaceutical R&D process. Its core businesses include: a catalog of specially designed scaffolds and building blocks; custom synthesis; process development; manufacturing of key intermediates and RSMs; and FTE services. The company was listed on Shenzhen Exchange Stock in China on November 10, 2017. PharmaBlock has rapidly gained recognition for its outstanding capability in the design, synthesis, and supply of lab scale building blocks. Building on that success, the company acquired Shandong Diai Biotechnology Co., Ltd. as its pilot plant and manufacturing site in 2016, and is providing scale-up synthesis and manufacturing of key intermediates/RSMs. PharmaBlock is now committed to a more comprehensive and long-term service to valued customers.